EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The zinc finger domains of PARP ‐1 are selectively and potently inhibited by the Au(I)‐based drugs sodium aurothiomalate and aurothioglucose

Uliana Bashtanova iD, Melinda Jane Duer

FEBS Letters · 2025

DOI: 10.1002/1873-3468.70224 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEBS Letters, 2025. Verfasst von Uliana Bashtanova und 1 weiteren Autor:innen. Beteiligte Einrichtung: Yusuf Hamied Department of Chemistry, University of Cambridge, UK. Hauptthemen laut MEDLINE: Poly (ADP-Ribose) Polymerase-1, Zinc Fingers, Poly(ADP-ribose) Polymerase Inhibitors. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cycle Pharmaceuticals Ltd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Poly(ADP‐ribose) polymerase‐1 (PARP‐1) is a multidomain enzyme essential for the DNA damage response; its inhibition can lead to cancer cell death. Recruitment of PARP‐1 to sites of genomic damage is mediated by its zinc finger domains. In this study, we investigated the inhibition of PARP‐1's DNA‐dependent activation by three Au(I)‐based drugs, presumable zinc‐ejectors. We found that aurothioglucose and sodium aurothiomalate selectively inhibited PARP‐1's DNA‐dependent activity, with IC 50 values in the nanomolar range, while preserving its DNA‐independent activity. Furthermore, in a BRCA‐mutated cell line, both compounds effectively suppressed DNA replication, with half‐maximal effective concentrations (EC 50 ) also in the nanomolar range. These findings highlight the potential of selective, zinc finger–targeting PARP‐1 inhibitors as promising candidates for anticancer drug testing. Impact statement The need to preserve basal poly(ADP‐ribose) polymerase‐1 (PARP‐1) activity in healthy cells, along with the search for alternative anticancer therapies in cases of drug resistance, led to the discovery of selective and potent zinc finger–targeting inhibitors of PARP‐1. This finding opens new opportunities for anticancer drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Poly (ADP-Ribose) Polymerase-1Zinc FingersPoly(ADP-ribose) Polymerase InhibitorsHumansDNA ReplicationCell Line, TumorAntineoplastic Agents

Stichwörter der Autor:innen

Poly(ADP‐ribose) polymeraseauranofinaurothioglucoseaurothiomalatesynthetic lethalityzinc finger

Substanzen

Poly (ADP-Ribose) Polymerase-1PARP1 protein, humanPoly(ADP-ribose) Polymerase InhibitorsAntineoplastic Agents

Autor:innen und Institutionen

  • Yusuf Hamied Department of Chemistry, University of Cambridge, UK.

ORCID-Profile: Uliana Bashtanova

Förderung

  • Cycle Pharmaceuticals Ltd

Zitieren

APA

Bashtanova, U., & Duer, M. J. (2025). The zinc finger domains of PARP ‐1 are selectively and potently inhibited by the Au(I)‐based drugs sodium aurothiomalate and aurothioglucose. FEBS Letters. https://doi.org/10.1002/1873-3468.70224

Vancouver

Bashtanova U, Duer MJ. The zinc finger domains of PARP ‐1 are selectively and potently inhibited by the Au(I)‐based drugs sodium aurothiomalate and aurothioglucose. FEBS Letters. 2025. doi:10.1002/1873-3468.70224

BibTeX
@article{Bashtanova2025,
  author = {Bashtanova, Uliana and Duer, Melinda Jane},
  title = {The zinc finger domains of PARP ‐1 are selectively and potently inhibited by the Au(I)‐based drugs sodium aurothiomalate and aurothioglucose},
  journal = {FEBS Letters},
  year = {2025},
  doi = {10.1002/1873-3468.70224}
}
Kostenlos starten →